• About
  • Policies
  • What is openaccess
  • Library
  • Contact
Advanced search
      View Item 
      •   BUIR Home
      • University Library
      • Bilkent Theses
      • Theses - Department of Molecular Biology and Genetics
      • Dept. of Molecular Biology and Genetics - Ph.D. / Sc.D.
      • View Item
      •   BUIR Home
      • University Library
      • Bilkent Theses
      • Theses - Department of Molecular Biology and Genetics
      • Dept. of Molecular Biology and Genetics - Ph.D. / Sc.D.
      • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Prediction of prognosis and chemosensitivity in gastrointestinal cancers

      Thumbnail
      Embargo Lift Date: 2020-01-02
      View / Download
      9.1 Mb
      Author
      Demirkol, Seçil
      Advisor
      Güre, Ali Osmay
      Date
      2018-01
      Publisher
      Bilkent University
      Language
      English
      Type
      Thesis
      Item Usage Stats
      126
      views
      142
      downloads
      Abstract
      Colon and gastric cancers are the third and fifth cancer types with the poorest survival. Surgery is considered the primary treatment option, which can be curative. However the decision as to whether chemotherapy administration after surgery is needed, is critical for especially stage 2 colon cancer; since a group of patients who receive chemotherapy do not have significantly improved clinical outcome. For this purpose, clinical risk factors are currently evaluated to determine patients with a high risk of progression. However this is not standardized by guidelines yet. Therefore, in this thesis my first aim was to ex vivo validate two novel independent mRNA based biomarkers, ULBP2 and SEMA5A, which have been previously identified in our lab, and to generate a prognostic signature which could stratify colon cancer patients with differential prognostic profiles using the best stratification method. I showed that a 3-group prognostic signature, SU-GIB, based on expression of these two genes is associated with cancer-specific, disease-free, and overall survival independent of clinical confounding factors in colon cancer. I performed in silico analysis in order to understand the biological details of the prognostic distinction, and revealed that patients with poorer prognosis show higher expression of pro-inflammatory cytokines and a more mesenchymal profile. Patients with better clinical outcome exhibit a more epithelial profile with higher levels of phosphorylated EGFR and Shc proteins. Analysis of high-throughput drug cytotoxicity databases also showed that colon cancer cell lines with „Bad‟ SU-GIB signature are more sensitive to a dual PI3K-MTOR inhibitor, BEZ235. In this thesis, my second goal was to define prognostic and molecular sub-groups for gastric cancer and characterize the specific biology of each sub-group. Utilizing an unsupervised approach on publicly available microarray data, I identified 3 biological groups, which harbor differential characteristics related to ECM involvement, EMT, proliferation and cell cycle. Moreover I identified distinct prognostic groups which are related to this molecular classification which can further stratify patients with known pathologic subtypes (diffuse and intestinal). I found that EMT was an important parameter for molecular and prognostic classifications for both types of cancers. I therefore, studied high-throughput drug cytotoxicity databases in order to identify selective compounds with selective growth inhibition on epithelial or mesenchymal cancer cells. I identified EGFR inhibitors as being significantly more effective on epithelial cancer cells regardless of the tissue type. My future plans include the large scale validation of SU-GIB, ex vivo validation of the gastric prognostic signature, and in vitro studies that would demonstrate effectivity of EGFR inhibitors on epithelial cancer cells and combination of EGFR inhibitors with MET inducers.
      Keywords
      EMT
      Colon cancer
      Gastric cancer
      Prognosis
      Biomarker
      Permalink
      http://hdl.handle.net/11693/35716
      Collections
      • Dept. of Molecular Biology and Genetics - Ph.D. / Sc.D. 70
      Show full item record

      Browse

      All of BUIRCommunities & CollectionsTitlesAuthorsAdvisorsBy Issue DateKeywordsTypeDepartmentsThis CollectionTitlesAuthorsAdvisorsBy Issue DateKeywordsTypeDepartments

      My Account

      Login

      Statistics

      View Usage StatisticsView Google Analytics Statistics

      Bilkent University

      If you have trouble accessing this page and need to request an alternate format, contact the site administrator. Phone: (312) 290 1771
      Copyright © Bilkent University - Library IT

      Contact Us | Send Feedback | Off-Campus Access | Admin | Privacy